Thomas Stankovich - 04 Aug 2023 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Nov 2023, 16:16:25 UTC
Prior SEC filing
19 Jul 2023
Next SEC filing
13 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Stankovich

Key filing fact

Thomas Stankovich filed Form 4 for ReShape Lifesciences Inc. (RSLS) on 08 Nov 2023.

Key facts

  • This page summarizes Thomas Stankovich's Form 4 filing for ReShape Lifesciences Inc. (RSLS).
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Nov 2023, 16:16.

Change

  • Previous filing in this sequence was filed on 19 Jul 2023.
  • Current net transaction value: -$386.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value
$154
Shares
-108
Change %
-0.46%
Price
$1.43
Shares after
23,276
Date
04 Aug 2023
Ownership
Direct
Footnotes
F1
RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value
$55.38
Shares
-39
Change %
-0.17%
Price
$1.42
Shares after
23,237
Date
24 Aug 2023
Ownership
Direct
Footnotes
F1
RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value
$105
Shares
-118
Change %
-0.51%
Price
$0.8900
Shares after
23,119
Date
01 Sep 2023
Ownership
Direct
Footnotes
F1
RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value
$36.27
Shares
-39
Change %
-0.17%
Price
$0.9300
Shares after
23,080
Date
11 Oct 2023
Ownership
Direct
Footnotes
F1
RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value
$35.37
Shares
-131
Change %
-0.57%
Price
$0.2700
Shares after
22,949
Date
25 Oct 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .